The aim of this webinar is to (a) present an overview of trends and opportunities on the Japanese cosmetics and quasi drugs market under the Corona pandemic, and to (b) deliver strategic insight, tactical guidance, and real-life examples of how to succeed in the market. This webinar includes:
The webinar targets (1) European SMEs selling cosmetics and/or quasi drugs products with an interest in entering the Japanese market, and (2) companies with an existing setup on the Japanese market but sending the need to rethink strategy: for example, by revitalising the company’s sales and marketing activities in the Japanese market.
In 40 minutes from your desk, discover:
Programme:
Registration deadline: 28 February 2022
Speaker: Martin Glisby is the founder and managing partner of Glisby & Associates, a consulting company with offices in Copenhagen and Tokyo, specialising in how to accelerate the speed and quality of collaborative arrangements with Japanese partners. Martin Glisby has held positions as chairman, CEO and board member of several companies with special reference to Japan. In recent years he has specialised in immersive M&A consultancy, becoming a facilitator working alongside, and trusted by, top management of both partners in Japanese cross-border M&As.
Moderator: Pauline Laloux, Business Support Coordinator, EU-Japan Centre
Organiser: EU-Japan Centre for Industrial Cooperation - Brussels Office
The EU-Japan Centre currently produces 5 newsletters :
Joint venture established in 1987 by the European Commission (DG GROW) and the Japanese Government (METI) for promoting all forms of industrial, trade and investment cooperation between the EU and Japan.
The EU-Japan Centre’s activities are subject to the allocation of a Grant Agreement by the European Commission for 2024-2026